Literature DB >> 18506569

Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.

Rezan Topaloğlu1, Nuray Aktay Ayaz, Hans R Waterham, Aysel Yüce, Fatma Gumruk, Ozden Sanal.   

Abstract

The hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) is an autoinflammatory syndrome. It is caused by the mutations of the mevalonate kinase gene. There is no consensus for specific therapy of HIDS, but there are some case reports and studies in regards to its treatment with drugs like colchicine, steroids, nonsteroid anti-inflammatory drugs, simvastatin, anakinra, thalidomide, and etanercept. We are reporting a case evaluated for the complaints of abdominal pain and febrile episodes with massive hepatomegaly, not common finding on physical examination, its treatment with etanercept, and long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506569     DOI: 10.1007/s10067-008-0911-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.

Authors:  J de Dios García-Díaz; M J Alvarez-Blanco
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

2.  Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean.

Authors:  R Topaloğlu; U Saatçi
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.

Authors:  E J Bodar; J C H van der Hilst; J P H Drenth; J W M van der Meer; A Simon
Journal:  Neth J Med       Date:  2005 Jul-Aug       Impact factor: 1.422

4.  Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene.

Authors:  E Rabinovich; A Livneh; P Langevitz; N Brezniak; E Shinar; M Pras; Y Shinar
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

5.  Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

Authors:  J P Drenth; L Cuisset; G Grateau; C Vasseur; S D van de Velde-Visser; J G de Jong; J S Beckmann; J W van der Meer; M Delpech
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

6.  Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  J P Drenth; A G Vonk; A Simon; R Powell; J W van der Meer
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

7.  Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.

Authors:  P D Arkwright; M F McDermott; S M Houten; J Frenkel; H R Waterham; E Aganna; L J Hammond; R M Mirakian; P I Tomlin; P I Vijaydurai; A J Cant
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

8.  Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  Anna Simon; Elizabeth Drewe; Jos W M van der Meer; Richard J Powell; Richard I Kelley; Anton F H Stalenhoef; Joost P H Drenth
Journal:  Clin Pharmacol Ther       Date:  2004-05       Impact factor: 6.875

9.  A patient with hyper-IgD syndrome in Antalya, Turkey.

Authors:  Erkan Coban; Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

10.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  J P Drenth; M van Deuren; J van der Ven-Jongekrijg; C G Schalkwijk; J W van der Meer
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  9 in total

Review 1.  Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.

Authors:  Svetlana Kostjukovits; Liisa Kalliokoski; Kaisu Antila; Matti Korppi
Journal:  Eur J Pediatr       Date:  2015-02-27       Impact factor: 3.183

Review 2.  Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis.

Authors:  Cailin Henderson; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 3.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

4.  Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey).

Authors:  Dıdem Arslan Tas; Suzan Dınkcı; Eren Erken
Journal:  Clin Rheumatol       Date:  2012-01-14       Impact factor: 2.980

5.  Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Authors:  Hiba M Shendi; Deirdre Walsh; J David M Edgar
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

6.  Nummular keratopathy in a patient with Hyper-IgD Syndrome.

Authors:  Courtney L Kraus; Susan M Culican
Journal:  Pediatr Rheumatol Online J       Date:  2009-08-05       Impact factor: 3.054

Review 7.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

Review 8.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

Review 9.  Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Luisa Costa; Mariangela Atteno; Adele Compagnone; Paolo Caso; Bruno Frediani; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Int J Rheumatol       Date:  2013-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.